Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−29.51 MXN
−890.44 M MXN
5.91 B MXN
19.88 M
About Fulgent Genetics, Inc.
Sector
Industry
CEO
Ming Hsieh
Website
Headquarters
El Monte
Founded
2016
FIGI
BBG00MQCNTN2
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
watching for continuation past resistance💸FLGT has a lovely setup here, broke its downtrend then successfully bounced on the retest.
now approaching local resistance/RSI resistance. If it breaks theres not much resistance left! and we will see price discovery to the upside
price targets are 122.26-144.42-166.32
like and follow for more!
In the time stress there is always a refuge! We are being bombarded by news from a new C-19 Variant. Market has reacted harshly to the news and S&P 500 dropped significantly. It was one of the most volatile black Fridays on the record! However, there are few stocks mostly the shining stars of pandemic that are lucrative to buy right now. I hav
FLGT - Fulgent Genetics - High probable long opportunityMy chart is giving a very high probable signal that $FLGT is going to reach $120 - $130 levels soon. The rejection of the down move with a strong bull candle shows that conviction. I shall be watching this. I am recording this observation for my reference. Feedback welcome.
FLGT Round 2I have been following and holding position in FLGT for past few weeks now, while every article here and elsewhere on the web point to FLGT being very bullish (frankly, past 2 weeks I only came cross 1 or 2 twits or post shorting FLGT), investor haven't been able to enjoy any return beyond 120 level.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of FLGT is 304.99 MXN — it has decreased by −31.54% in the past 24 hours. Watch FULGENT GENETICS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange FULGENT GENETICS, INC stocks are traded under the ticker FLGT.
FLGT stock has fallen by −2.32% compared to the previous week, the month change is a −2.32% fall, over the last year FULGENT GENETICS, INC has showed a −17.69% decrease.
We've gathered analysts' opinions on FULGENT GENETICS, INC future price: according to them, FLGT price has a max estimate of 494.18 MXN and a min estimate of 329.46 MXN. Watch FLGT chart and read a more detailed FULGENT GENETICS, INC stock forecast: see what analysts think of FULGENT GENETICS, INC and suggest that you do with its stocks.
FLGT stock is 46.07% volatile and has beta coefficient of 0.16. Track FULGENT GENETICS, INC stock price on the chart and check out the list of the most volatile stocks — is FULGENT GENETICS, INC there?
Today FULGENT GENETICS, INC has the market capitalization of 10.93 B, it has decreased by −5.21% over the last week.
Yes, you can track FULGENT GENETICS, INC financials in yearly and quarterly reports right on TradingView.
FULGENT GENETICS, INC is going to release the next earnings report on May 2, 2025. Keep track of upcoming events with our Earnings Calendar.
FLGT earnings for the last quarter are 0.83 MXN per share, whereas the estimation was −2.56 MXN resulting in a 132.61% surprise. The estimated earnings for the next quarter are −3.68 MXN per share. See more details about FULGENT GENETICS, INC earnings.
FULGENT GENETICS, INC revenue for the last quarter amounts to 1.59 B MXN, despite the estimated figure of 1.56 B MXN. In the next quarter, revenue is expected to reach 1.46 B MXN.
FLGT net income for the last quarter is −122.76 M MXN, while the quarter before that showed −288.62 M MXN of net income which accounts for 57.47% change. Track more FULGENT GENETICS, INC financial stats to get the full picture.
No, FLGT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 1.31 K employees. See our rating of the largest employees — is FULGENT GENETICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FULGENT GENETICS, INC EBITDA is −1.02 B MXN, and current EBITDA margin is −17.28%. See more stats in FULGENT GENETICS, INC financial statements.
Like other stocks, FLGT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FULGENT GENETICS, INC stock right from TradingView charts — choose your broker and connect to your account.